Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer

A pharmacological-based global screen for epigenetically silenced tumor suppressor genes was performed in MCF-7 and MDA-MB-231 breast cancer cells. Eighty-one genes in MCF-7 cells and 131 in MDA-MB-231 cells were identified, that had low basal expression and were significantly upregulated following treatment. Eighteen genes were studied for methylation and/or expression in breast cancer; PTCH, the receptor for the hedgehog (Hh) pathway and a known tumor suppressor gene, was selected for further analysis. Methylation of the PTCH promoter was found in MCF-7 cells and in breast cancer samples, and correlated with low PTCH expression. Immunohistochemical analysis of breast tissue arrays revealed high expression of PTCH in normal breast compared to ductal carcinomas in situ (DCIS) and invasive ductal carcinomas; furthermore, association was found between PTCH expression and favorable prognostic factors. PTCH is an inhibitor of the Hh pathway, and its silencing activates the pathway and promotes growth. Indeed, high activity of the Hh pathway was identified in MCF-7 cells and overexpression of PTCH inhibited the pathway. Moreover, treatment with cyclopamine, an inhibitor of the pathway, reduced cell growth and slowed the cell cycle in these cells. Thus, unmasking of epigenetic silencing in breast cancer enabled us to discover a large number of candidate tumor suppressor genes. Further analysis suggested a role of one of these genes, PTCH, in breast cancer tumorigenesis.

[1]  J. Taipale,et al.  Patched acts catalytically to suppress the activity of Smoothened , 2002, Nature.

[2]  Sepideh Shaker,et al.  Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3σ, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells , 2003, Anti-cancer drugs.

[3]  M. Esteller,et al.  Histone deacetylase inhibitors: Understanding a new wave of anticancer agents , 2004, International journal of cancer.

[4]  M. Hendrix,et al.  Aberrant methylation of the maspin promoter is an early event in human breast cancer. , 2004, Neoplasia.

[5]  T. Miyashita,et al.  Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons. , 2005, Genomics.

[6]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[7]  Michael Dean,et al.  Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.

[8]  Frank McCormick,et al.  Activation of the hedgehog pathway in advanced prostate cancer , 2004, Molecular Cancer.

[9]  Martin Widschwendter,et al.  DNA methylation and breast carcinogenesis , 2002, Oncogene.

[10]  M. Rosemann,et al.  Unbalanced overexpression of the mutant allele in murine Patched mutants. , 2002, Carcinogenesis.

[11]  M. Scott,et al.  Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. , 1997, Cancer research.

[12]  David M. Berman,et al.  Tissue repair and stem cell renewal in carcinogenesis , 2004, Nature.

[13]  B. Mitchell,et al.  Role of Estrogen Receptor in the Regulation of Ecto-5′-Nucleotidase and Adenosine in Breast Cancer , 2004, Clinical Cancer Research.

[14]  J. Chang-Claude,et al.  The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk , 2003, International journal of cancer.

[15]  C. James,et al.  Sporadic medulloblastomas contain PTCH mutations. , 1997, Cancer research.

[16]  C. Sugnet,et al.  The Gli2 transcription factor is required for normal mouse mammary gland development. , 2001, Developmental biology.

[17]  T. Kawase,et al.  Patched and Smoothened MRNA Expression in Human Astrocytic Tumors Inversely Correlates with Histological Malignancy , 2004, Journal of Neuro-Oncology.

[18]  Joachim Diebold,et al.  Functional epigenomics identifies genes frequently silenced in prostate cancer. , 2005, Cancer research.

[19]  G. Page,et al.  Hedgehog signaling and response to cyclopamine differs in epithelial and stromal cells in benign breast and breast cancer , 2006, Cancer biology & therapy.

[20]  Masatoshi Nomura,et al.  Hedgehog Signaling Pathway is a New Therapeutic Target for Patients with Breast Cancer , 2004, Cancer Research.

[21]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[22]  B. Karlan,et al.  15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. , 2006, Cancer research.

[23]  J. Tomaszewski,et al.  PTCH gene mutations in invasive transitional cell carcinoma of the bladder , 1998, Oncogene.

[24]  M. Scott,et al.  Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine , 2000, Nature.

[25]  S. Nishizuka,et al.  Mutations in the human homologue of the Drosophila patched gene in esophageal squamous cell carcinoma , 1998, Genes, chromosomes & cancer.

[26]  P. McCrea,et al.  Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer , 1999 .

[27]  A. Oniscu,et al.  Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia , 2004, The Journal of pathology.

[28]  James M. Olson,et al.  Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade , 2002, Science.

[29]  Peter A. Jones,et al.  Discovery of Epigenetically Masked Tumor Suppressor Genes in Endometrial Cancer , 2005, Molecular Cancer Research.

[30]  S. Tauber,et al.  A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing. , 2005, International journal of oncology.

[31]  M. Lacroix,et al.  Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.

[32]  J. Christman,et al.  5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy , 2002, Oncogene.

[33]  M. Lewis,et al.  Next Stop, the Twilight Zone: Hedgehog Network Regulation of Mammary Gland Development , 2004, Journal of Mammary Gland Biology and Neoplasia.

[34]  N. Rosen,et al.  The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. , 2001, Cancer research.

[35]  M. Hendrix,et al.  Epigenetic silencing of maspin gene expression in human breast cancers , 2000, International journal of cancer.

[36]  Yutaka Shimada,et al.  Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.

[37]  Yusuke Nakamura,et al.  Allelic Loss on Chromosome 9q Is Associated with Lymph Node Metastasis of Primary Breast Cancer , 1998, Japanese journal of cancer research : Gann.

[38]  F. Sato,et al.  Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. , 2002, Cancer cell.

[39]  D. Krause,et al.  Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein , 2002, Oncogene.

[40]  M. Cohen,et al.  The hedgehog signaling network , 2003, American journal of medical genetics. Part A.

[41]  S. Nomoto,et al.  Inverse Correlation between Cyclin A1 Hypermethylation and p53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing , 2004, Cancer Research.

[42]  M. Toyota,et al.  Methylation profiling in acute myeloid leukemia. , 2001, Blood.

[43]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.

[44]  Stephen B. Baylin,et al.  Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer , 2003, Nature.

[45]  P. Walsh.  Hedgehog signalling in prostate regeneration, neoplasia and metastasis. , 2005, The Journal of urology.

[46]  M. Szyf,et al.  DNA methylation and breast cancer. , 2004, Biochemical pharmacology.

[47]  Yu Liang,et al.  Evidence for lack of enhanced hedgehog target gene expression in common extracutaneous tumors. , 2003, Cancer research.

[48]  S. Cohen,et al.  Hedgehog Induces Opposite Changes in Turnover and Subcellular Localization of Patched and Smoothened , 2000, Cell.

[49]  M. Scott,et al.  Basal cell carcinomas in mice overexpressing sonic hedgehog. , 1997, Science.

[50]  C. Sugnet,et al.  Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. , 1999, Development.

[51]  M. Datta,et al.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Baylin,et al.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.